Clinical Drug Experience Knowledgebase

Abnormalities, Drug-Induced (Phase 4)

Aggression (Phase 1)

Aortic Coarctation (Phase 4)

Apnea (Phase 2)

Atherosclerosis (Phase 4)

Atrial Fibrillation (Phase 4)

Atrial Remodeling (Phase 4)

Bipolar Disorder (Phase 2)

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Cardiomyopathies (Phase 4)

Cardiomyopathy, Dilated (Phase 4)

Cardiovascular Diseases (Phase 2)

Carotid Stenosis (Phase 2)

Cerebral Hemorrhage (Phase 2)

Cognitive Dysfunction (Phase 2)

Congenital Abnormalities (Phase 2)

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Death, Sudden (Phase 2)

Disease (Phase 2)

Heart Arrest (Phase 3)

Heart Defects, Congenital (Phase 2)

Heart Diseases (Phase 4)

Heart Failure (Phase 3)

Heart Failure, Systolic (Phase 4)

Hemorrhage (Phase 2)

Hyperlipidemias (Phase 4)

Hypersensitivity (Phase 4)

Hypertension (Phase 4)

Hypotension (Phase 2)

Infarction (Phase 2)

Inflammation (Phase 4)

Insulin Resistance (Phase 4)

Jervell-Lange Nielsen Syndrome (Phase 2)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 1)

Long QT Syndrome (Phase 4)

Metabolic Syndrome (Phase 1)

Multiple Trauma (Phase 2)

Myocardial Infarction (Phase 2)

Myocardial Ischemia (Phase 2)

Obesity (Phase 2)

Out-of-Hospital Cardiac Arrest (Phase 3)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 2)

Prediabetic State (Phase 4)

Prehypertension (Phase 2)

Psychotic Disorders (Phase 2)

Recurrence (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Sarcoidosis (Phase 2)

Schizophrenia (Phase 2)

Shock (Phase 2)

Shock, Septic (Phase 2)

Sleep Apnea, Obstructive (Phase 2)

Sleep Apnea Syndromes (Phase 2)

Stress Disorders, Post-Traumatic (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Subarachnoid Hemorrhage (Phase 2)

Syndrome (Phase 1)

Tachycardia (Phase 3)

Torsades de Pointes (Phase 4)

Vasospasm, Intracranial (Phase 2)

Ventricular Fibrillation (Phase 3)

Ventricular Remodeling (Phase 4)

Wounds and Injuries (Phase 2)